Psychemedics Cash Flow from Investing Activities 2010-2024 | PMD

Psychemedics cash flow from investing activities from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
Psychemedics Annual Cash Flow Investing
(Millions of US $)
2024 $-0
2023 $-0
2022 $-0
2021 $-0
2020 $-1
2019 $2
2018 $-5
2017 $-1
2016 $-2
2015 $-2
2014 $-8
2013 $-2
2012 $-2
2011 $1
2010 $-2
2009 $-1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.777B 18.97
DaVita (DVA) United States $12.238B 15.61
Encompass Health (EHC) United States $10.200B 22.86
Chemed (CHE) United States $9.006B 28.86
Option Care Health (OPCH) United States $5.740B 27.52
Elanco Animal Health (ELAN) United States $5.213B 11.54
RadNet (RDNT) United States $3.681B 78.92
Amedisys (AMED) United States $3.039B 21.49
LifeStance Health (LFST) United States $2.561B 0.00
Addus HomeCare (ADUS) United States $1.797B 20.82
Astrana Health (ASTH) United States $1.554B 34.84
U.S Physical Therapy (USPH) United States $1.099B 28.05
Aveanna Healthcare Holdings (AVAH) United States $1.057B 0.00
Pennant (PNTG) United States $0.866B 34.93
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Bioqual (BIOQ) United States $0.051B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.002B 0.00